-
Germline variants in patients diagnosed with both uveal and cutaneous melanoma
Study
EGAS00001007584
-
Genomic landscape of malignant peripheral nerve sheath tumor (MPNST)
Study
EGAS00001006069
-
Integrative_Oncogenomics_of_Multiple_Myeloma
Study
EGAS00001000036
-
Chondrosarcoma_Exome_
Study
EGAS00001000038
-
USARC 10X Genomics Single Cell DNA Sequencing Data
Study
EGAS00001006144
-
Integration of genomics and histology reveals diagnosis and effective therapy of refractory cancer of unknown primary with PDL1 amplification (H021)
Study
EGAS00001001846
-
Exome_sequencing_of_EBV_driven_lymphoma
Study
EGAS00001001021
-
Whole-exome sequencing of extranodal NK/T cell lymphoma
Study
EGAS00001004357
-
The impact of mutational clonality in predicting the response to anti-PD-L1/PD-L1 in advanced urothelial cancer
Study
EGAS00001007086
-
Delineating intratumoural heterogeneity and neoantigen-directed immune escape in Esophageal Squamous Cell Carcinoma
Study
EGAS00001003832
-
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Study
EGAS00001007160
-
Molecular and clinical diversity in primary central nervous system lymphoma: a LOC Network study
Study
EGAS00001006191
-
WGS of 32 paired SRCC samples
Study
EGAS00001002668
-
Monocyte Spike-in RNASeq
Study
EGAS00001007197
-
WES used for direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Study
EGAS00001002050
-
Integrated Molecular Profilting in Advanced Cancers Trial
Study
EGAS00001001897
-
Comparison of EGF and PDGF driven glioblastomas.
Study
EGAS00001001900
-
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Study
EGAS00001000399
-
Transcriptomic analysis of the Phase 3 COMPARZ clinical trial
Study
EGAS00001004534
-
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
Study
EGAS00001006293
-
Whole genome landscape of 25 metastatic cutaneous squamous cell carcinoma cSCC patients
Study
EGAS00001006378
-
Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers
Study
EGAS00001006331
-
The molecular landscape of glioma in patients with Neurofibromatosis 1.
Study
EGAS00001003186
-
Genomic landscape and molecularly-informed therapy in thymic carcinoma and other advanced thymic epithelial tumors (H021, HIPO)
Study
EGAS00001006408
-
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Study
EGAS00001006400